Biobank Regulation and MTA templates are open for consultation!
As the main users, you get the opportunity to review these two main Governance documents. Please take the chance to comment before publication!
Thank you for your participation!
This conference, held on February 1 at EPFL – Lausanne, featured international and national experts sharing their vision of the biobanking of the future
VISION AND MISSION
A RELIABLE NETWORK
SBP’s vision is to help Switzerland consolidate its position at the forefront of biomedical research by facilitating access and optimal usage of its existing and future biobanked specimens.
Considering the fact that sample quality is the cornerstone of a biobank’s reputation, the SBP mission is to develop a reliable customer-oriented network of biobanks in Switzerland with harmonized processes in terms of:
- General information and consent of citizens (including patients)
- Preanalytical conditions for sample processing and storage
- Laboratory informatics management system associated with samples, data storage and confidentiality
- Annotation of samples and data
- Traceability, access and distribution of samples and
data for research purposes
- Support to investigators
- Biobank sustainability
Production of harmonized process
To that end, SBP shall develop the following objectives which are clearly defined in an agreement co-signed 29th June 2015 by SNSF, SAMS and the project group:
- Setup of a professional organization in close collaboration with the 5 University Hospitals
- Creation of a central web based catalogue of existing and de novo biobanks with data and samples’ access policies
- Integration of non-human biobanks
- Coordination and harmonization
of biobanking activities
- Support in terms of legal, ethical and societal issues (ELSI)
- Implementation of a proof of concept study for the credibility
of the platform
- Representation and evolution as the Swiss node in the BBMRI network
- Development of a business model to ensure sustainable funding of the SBP
The SBP will be deployed in four phases with the launch of the platform in 2015, the analysis of existing biobanks in 2016, the establishment of harmonized procedures by 2017 that will be implemented in a pilot feasibility study as soon as 2018.
To provide guidance to Swiss Institutions willing to set up and use the national Consent for Research, SBP releases Best Practices – General Consent for Research in support of the consent documents developed by SAMS/Swissethics.
The business of SBP is conducted by the Governing Board, composed of the founding members of SBP association, representing non-profit organizations officially commissioned to conduct biobanking activities.
Prof. Vincent Mooser, President
Head Laboratory Department at CHUV
Prof. Tosso Leeb
Head Institute of Genetics,
Vetsuisse Faculty, Bern
Prof. Aurel Perren, Vice-President
IDirector Institute of Pathology,
University Hospital Bern
Prof. Nicole Probst-Hensch
Head Unit Chronic Disease
Epidemiology, Swiss TPH Basel
Prof. Christoph Meier
Prof. Matthias Gugger
Prof. Antoine Geissbühler
Prof. Jean-Daniel Tissot
Prof. Gabriela Senti
Implementation of SBP’s objectives is under the responsibility of the executive office led by Christine Currat, PhD.